Siegfried Holding EBIT Margin

What does Siegfried Holding do? Siegfried Holding AG generates revenue through the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates for pharmaceutical clients. The company provides contract development and manufacturing services for APIs, intermediates, and controlled substances, serving clients with research and development programs. Its drug products portfolio includes licensing and contract or co-development and manufacturing of oral solids and steriles. The firm targets pharmaceutical companies seeking to outsource production of treatments for hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia, bipolar disorders, and diabetes. Production facilities in Switzerland, Germany, France, Malta, the United States, and China support these operations. Siegfried Holding AG’s business model focuses on serving pharmaceutical clients who require specialized manufacturing capabilities for both drug substances and drug products. The company’s APIs and intermediates are developed for specific therapeutic areas, including cardiovascular conditions like hypertension and benign prostate hyperplasia, as well as neurological and psychiatric disorders such as depression, schizophrenia, and bipolar disorders. The firm’s manufacturing services are tailored to meet the needs of clients developing treatments for chronic conditions like diabetes and asthma. Contracts with pharmaceutical firms for these services form the core of the company’s revenue streams. The company’s production facilities across multiple countries enable it to serve a global client base. By offering both drug substance and drug product manufacturing, Siegfried Holding AG provides comprehensive solutions for pharmaceutical clients. Its services include contract development and manufacturing of APIs, intermediates, and controlled substances, alongside licensing and co-development of oral solid and sterile drug products. These offerings cater to clients seeking to outsource complex manufacturing processes for treatments targeting a wide range of medical conditions, from cardiovascular to neurological disorders. Siegfried Holding is one of the most popular companies on Eulerpool.